Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
Journal: Journal of the renin-angiotensin-aldosterone system : JRAAS
Published: August 18, 2017
A decade of innovation in pharmaceutical R&D: the Chorus model.
Journal: Nature reviews. Drug discovery
Published: December 16, 2014
Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 01, 2013
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes.
Journal: Diabetes care
Published: March 22, 2013
Showing 1-4 of 4
Last Updated: 09/26/2026